Accelerate Clinical Biomarker Development & Commercial Success with Accessible Liquid Biopsy Testing
Time: 8:50 am
day: Day 2 AM
Details:
- Harness epigenomic insights for more effective cancer therapies: Identify the right patients and improve therapeutic response
- Building the flexible CDx strategies and accelerating commercial success with data-driven insights
- Expanding global access for clinical trials and liquid biopsy testing
